Related Experiment Videos
Minimizing the non-extrapyramidal side-effects of antipsychotics
1Monash University, Melbourne, Australia.
Acta Psychiatrica Scandinavica. Supplementum
|January 1, 1996
Summary
New antipsychotics like risperidone offer improved tolerability and fewer side effects compared to older drugs. Careful patient selection and management strategies can minimize adverse events, enhancing long-term treatment quality of life.
Area of Science:
- Psychiatry and Pharmacology
- Neuroscience
- Clinical Therapeutics
Background:
- Standard neuroleptic medications are being supplemented by newer agents such as risperidone and clozapine.
- While newer antipsychotics show reduced extrapyramidal side effects, they can still cause serious adverse events impacting patient quality of life.
Purpose of the Study:
- To review the adverse effects of both standard and novel antipsychotic medications.
- To highlight strategies for minimizing side effects and improving patient outcomes.
Main Methods:
- Review of clinical literature on antipsychotic efficacy and adverse effects.
- Analysis of specific side effects including postural hypotension, cardiotoxicity, anticholinergic effects, sedation, weight gain, and endocrine/hematological changes.
Main Results:
- Antipsychotic medications, old and new, present a spectrum of adverse effects, some severe.
- Significant differences exist in the propensity for side effects among various antipsychotic compounds.
- Risperidone is noted for good tolerability and fewer side effects.
Conclusions:
- Optimization of clinical strategies, including drug selection, slow titration, and dosage adjustment, can mitigate side effects.
- Patient and caregiver education regarding potential side effects is crucial for long-term adherence and quality of life.
- The choice of antipsychotic should be individualized based on a patient's risk profile for adverse effects, with newer agents like risperidone considered for first-line treatment.